Engineering the future of precision medicine
Obsidian Therapeutics (obsidiantx.com) scores 77 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, in the 58th percentile of 19322 Healthcare brands.
Obsidian Therapeutics is a biopharmaceutical company developing next-generation engineered cell therapies for difficult-to-treat cancers. Its proprietary cytoDRiVE platform uses drug-responsive domains (DRDs) to regulate protein function with FDA-approved small-molecule drugs, enabling precise control over therapies such as TIL-based treatments. The company positions itself as a pioneer in precision cell therapy, targeting biopharmaceutical stakeholders, clinicians, researchers, patients with cancers like melanoma, and investors in the cell and gene therapy space.
| Brand Name | Obsidian Therapeutics |
|---|---|
| Domain | obsidiantx.com |
| Industry | Healthcare |
| Main Competitors | Iovance Biotherapeutics (76/100), Lyell Immunopharma (78/100), Arsenal Biosciences (74/100), Senti Biosciences (79/100), Arcellx (82/100), Allogene Therapeutics (83/100), bluebird bio (57/100), Cellectis (81/100) |
Moz Domain Authority 31/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Obsidian Therapeutics is using its proprietary cytoDRiVE® platform to harness the power of proteins to engineer precision medicines." (Meta description: 18 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Breadcrumb/Website schema, og:title, og:description, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Nginx, WordPress, Ghost.
Social footprint: verified profiles on X (Twitter), LinkedIn, Facebook, Instagram, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Obsidian Therapeutics?", Claude could identify the brand as of October 2026. Obsidian Therapeutics is a biotech company developing engineered cell and gene therapies, with a focus on calibrated, controllable cell therapy products using technologies like their destabilizing domain and RNA-based switch platforms to fine-tune how engineered cells behave in t Best known for developing tunable, controllable cell and gene therapy platforms, including work on calibrated CAR-T cell therapies.
When asked "Best brands similar to Obsidian Therapeutics?", Claude would recommend Obsidian Therapeutics as of October 2026. It's a notable name in next-generation cell therapy engineering, so it would come up alongside other synthetic biology and cell therapy companies working on control mechanisms for engineered therapeutics.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Obsidian Therapeutics's main competitors in Healthcare: Iovance Biotherapeutics (76/100), Lyell Immunopharma (78/100), Arsenal Biosciences (74/100), Senti Biosciences (79/100), Arcellx (82/100).
Sources: Brand Analyzer scan
Obsidian Therapeutics has low AI-search visibility, scoring 20/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 30, recommendation 45). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Obsidian Therapeutics official site
Obsidian Therapeutics scores 45/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Obsidian Therapeutics official site
Obsidian Therapeutics' core offering is its proprietary cytoDRiVE platform, which incorporates drug-responsive domains (DRDs) into engineered cell therapies. This technology is applied to develop controllable cell and gene therapies, including TIL-based (tumor-infiltrating lymphocyte) treatments, aimed at cancers such as melanoma.
Sources: Obsidian Therapeutics official site
Obsidian Therapeutics is a biopharmaceutical company focused on engineering precision cell therapies. It uses its proprietary cytoDRiVE platform, which applies drug-responsive domains (DRDs) to control protein function in engineered cells, to develop next-generation treatments for difficult-to-treat cancers such as melanoma.
Sources: Obsidian Therapeutics official site
Obsidian Therapeutics develops engineered cell and gene therapies using its proprietary cytoDRiVE platform. This platform employs drug-responsive domains (DRDs) that allow protein function within engineered cells to be regulated using FDA-approved small-molecule drugs, enabling precise, controllable therapeutic effects, including in TIL-based (tumor-infiltrating lymphocyte) cancer treatments.
Sources: Obsidian Therapeutics official site
Obsidian Therapeutics can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Obsidian Therapeutics official site
Obsidian Therapeutics is known for its proprietary cytoDRiVE platform, which uses drug-responsive domains (DRDs) to give precise, drug-controllable regulation over protein function in engineered cell therapies, particularly TIL-based treatments for cancers like melanoma.
Sources: Obsidian Therapeutics official site
Obsidian Therapeutics' work is relevant to biopharmaceutical industry stakeholders, clinicians, and researchers involved in cell and gene therapy development, as well as patients with advanced cancers such as melanoma who may be treated with therapies built on its platform. Investors interested in cell and gene therapy innovation also engage with the company.
Sources: Obsidian Therapeutics official site
Obsidian Therapeutics scores 20/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Obsidian Therapeutics has a weak AI-visibility profile at 20/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (45/100) and its weakest is visibility (0/100). It benefits from open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and a low Moz Domain Authority of 31/100. In a live check, Claude could already identify Obsidian Therapeutics from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Obsidian Therapeutics: ObboMed (77/100), National Youth Advocate Program (NYAP) (77/100), The Ottawa Hospital Foundation (77/100), O'Keeffe's (77/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.